Celldex Therapeutics, Inc

CLDXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
35.35 USD
↘ 0.05 (0.14%)AT CLOSE (11:59 AM EDT)
35.56
↗ 0.21 (0.59%)
POST MARKET (AS OF 04:36 PM EDT)
Post Market
AS OF 04:36 PM EDT
35.56
↗ 0.21 (0.59%)
🟢Market: OPEN

Shares of Celldex Therapeutics, Inc (CLDX) are trading at $38.48. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jul 17, 2026.

Open?$34.71
High?$36.04
Low?$34.37
Prev. Close?$35.40
Volume?1.1M
Avg. Volume?1.2M
VWAP?$35.30
Rel. Volume?0.99x
Bid / Ask
Bid?$30.60 × 100
Ask?$41.96 × 100
Spread?$11.36
Midpoint?$36.28
Valuation & Ratios
Market Cap?2.8B
Shares Out?78.5M
Float?70.9M
Float %?90.3%
P/E Ratio?N/A
P/B Ratio?6.09
EPS?-$3.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
198
Market Cap
2.8B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
www.celldex.com
Listed
1986-05-15
Address
53 FRONTAGE ROAD
HAMPTON, NJ 08827
Phone: 908-200-7500
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
18
Short Sent.?
35
Piotroski F-Score?1/9Weak
Altman Z-Score?24.08Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.91%High
Short Interest?7.7M
Days to Cover?4.3
Free Float70.9M
Avg Daily Volume1.8M
Settlement Date2026-06-30
Financial Health
Current Ratio?8.92Strong
Quick Ratio?8.92Strong
Cash Ratio?0.69Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
30
6.09FAIR▾
P/S?
Peers
100
S&P
3
3,208.57HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
3,167.31HIGH▾
Returns & Efficiency
ROE?
S&P
3
-62.2%WEAK▾
ROA?
S&P
3
-55.5%WEAK▾
Cash Flow & Enterprise
FCF?$-226249000
Enterprise Value?$2.7B
Fundamentals ratios updated end of day
MarketsMoversWatchlist